• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

ECDC: First human case of influenza A(H9N2) infection imported in the EU

Commonground

Senior Moderator
25 March 2026

A human case of avian influenza A(H9N2) infection in a returning traveller from a non-European country where the virus has previously been identified in birds, has been reported in the Lombardy region of Italy. This is the first human case of avian influenza A(H9N2) reported in the EU/EEA.

The patient has co-existing medical conditions and is currently in hospital isolation, receiving medical treatment. Italian public health authorities performed contact tracing as a precaution to identify and control possible onward transmission and initiated several epidemiological and microbiological investigations.

Since 1998, and as of 27 February 2026, 195 human cases of A(H9N2) had been reported worldwide by 10 countries in Asia and Africa. Only two infections were fatal. No clusters of human influenza A(H9N2) infections, nor documented instances of person-to-person transmission, have ever been reported. Direct contact with infected birds or contaminated environments has been the most likely source of human infection for avian influenza viruses. Sporadic human cases of avian influenza are not unexpected in areas where the virus is circulating in birds.

Based on information shared by Italian public health authorities and knowledge of the virus epidemiology, ECDC currently assesses the risk for the general population in the EU/EEA of influenza A(H9N2) related to this event as very low. ECDC is in contact with authorities in Italy and is monitoring the situation closely and will reassess the risk as more information becomes available.

ECDC monitors the epidemiology of zoonotic influenza and the circulation of avian influenza strains through epidemic intelligence activities and sharing information among international partners. Together with the European Food Safety Authority (EFSA) and the EU Reference Laboratory for Avian Influenza, ECDC produces a quarterly report on the avian influenza situation in the EU/EEA. The most recent report was published in March 2026. ECDC has also published a protocol for the investigation and management of human infections in the EU/EEA as well as a pre-pandemic influenza scenario framework with suggested public health actions when human cases in the EU/EEA are detected.

https://www.ecdc.europa.eu/en/news-events/first-human-case-influenza-ah9n2-infection-imported-eu
 
Back
Top